Aspira Women’s Health Inc. Operating Income Loss

• Aspira Women's Health Inc. showed an increase of +13.7% in Operating Income Loss from 2023 to 2024.
• This data is from Aspira Women's Health Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
• XBRL data for this metric is available from 2010 to 2024 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 15 years of available data (2010 to 2024), Aspira Women's Health Inc.'s Operating Income Loss has declined by 11.5%.
• Historical annual values: Fiscal year 2024: -$16.28 million | Fiscal year 2023: -$18.85 million | Fiscal year 2022: -$31.14 million | Fiscal year 2021: -$32.60 million | Fiscal year 2020: -$17.98 million | Fiscal year 2019: -$15.28 million | Fiscal year 2018: -$11.33 million | Fiscal year 2017: -$10.44 million | Fiscal year 2016: -$14.95 million | Fiscal year 2015: -$19.25 million | Fiscal year 2014: -$19.21 million | Fiscal year 2013: -$8.86 million | Fiscal year 2012: -$9.41 million | Fiscal year 2011: -$17.64 million | Fiscal year 2010: -$14.60 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026